Viewing Study NCT00949650


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-02-01 @ 9:01 AM
Study NCT ID: NCT00949650
Status: COMPLETED
Last Update Posted: 2018-04-06
First Post: 2009-07-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
Sponsor:
Organization: